Mutation of β-catenin does not coexist with K-ras mutation in colorectal tumorigenesis

Digestive Diseases and Sciences

Volumn 49, Issue 10, 2004, Pages 1631-1633

  Shitoh, Kazuhisa ^a   Koinuma, Koji ^a   Furukawa, Taiji ^a   Okada, Masaki ^a   Nagai, Hideo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

catenin; colorectal carcinoma; cyclin D1; K ras

Indexed keywords

BETA CATENIN; CYCLIN D1; K RAS PROTEIN;

ARTICLE; CARCINOGENESIS; CODON; COLORECTAL CARCINOMA; CONTROLLED STUDY; EXON; FAMILY HISTORY; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAMPLING; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION;

BETA CATENIN; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, RAS; HUMANS; MUTATION; TRANS-ACTIVATORS;

EID: 5044221069     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000043376.41820.a6     Document Type: Article

References (14)

1. Kinzler KW, Vogelstein B: Lesson from hereditary colorectal cancer. Cell 87:159-170, 1996
2. Kinzle KW, Vogelstein B: Landscaping the cancer terrain. Science 280:1036-1037, 1998
3. Vogelstein B, Fearon ER, Hamilton SR, et al.: Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532, 1998
4. Abraham SC, Montgomery EA, Giardiello FM, Wu TT: Frequent β-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol 158:1073-1078, 2001
5. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelatein B, Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutation in β-catenin or APC. Science 275:1787-1790, 1997
6. Nilbert M, Rambech E: β-Catenin activation through mutation is rare in rectal cancer. Cancer Genet Cytogenet 128:43-45, 2001
7. Mirabelli-Primdahl L, Gryfe R, Kim H, Millar A, Luceri C, Dale D, Holowaty E, Bapat B, Gallinger S, Redston M: β-Catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res 59:3346-3351, 1999
8. Kitaeva MN, Grogan L, Williams JP, Dimond E, Nakahara K, Hauser P, DeNobile JW, Soballe PW, Ilan RK: Mutations in β-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res 57:4478-4481, 1997
9. Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, Ishiguro S, Nakamura Y, Miyoshi Y: Activation of the β-catenin gene interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58:1021-1026, 1998
10. Sparks AB, Morin PJ, Vogekstein B, Kinzler KW: Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130-1134, 1998
11. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A: Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J 17:1371-1384, 1998
12. Kikuchi A: Modulation of Wnt signaling by Axin and Axil. Cytokine growth factor Rev 10:255-265, 1999
13. He TC, Sparks AB, Rago C, et al.: Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512, 1998
14. Tetsu O, McCormick F: β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426, 1999